Cited by 358Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental ValuationGlobal Health Care Issues

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

A Practical Guide for Calculating Indirect Costs of Disease

Koopmanschap, Marc A., Rutten, Frans F.H.·1996·PharmacoEconomics

DOI 10.2165/00019053-199610050-00003

Open this paper in CoChat — free account

Abstract

There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs. This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes. Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.

Integrity signals

Registry

Crossref · 10.2165/00019053-199610050-00003

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The friction cost method for measuring indirect costs of disease
Koopmanschap, M. A., Rutten, F., van Ineveld, B. M., & Roijen, L. H. (1995) · Journal of Health Economics · doi:10.1016/0167-6296(94)00044-5 · Cited by 1,141
Self-citation
Economics of coronary artery bypass grafting.
Williams, A. (1985) · BMJ · doi:10.1136/bmj.291.6491.326 · Cited by 718
Cost-of-Illness Studies
Drummond, M. (1992) · PharmacoEconomics · doi:10.2165/00019053-199202010-00001 · Cited by 489
Labor and Health Status in Economic Evaluation of Health Care: The Health and Labor Questionnaire
Roijen, L. H., Essink‐Bot, M., Koopmanschap, M., Bonsel, G. J., & Rutten, F. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009764 · Cited by 308
Self-citation
Indirect Costs in Economic Studies
Koopmanschap, M. A., & Rutten, F. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304060-00006 · Cited by 170
Self-citation
The Cost of Diabetes
Gerard, K., Donaldson, C., & Maynard, A. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb02107.x · Cited by 145
The impact of indirect costs on outcomes of health care programs
Koopmanschap, M. A., & Rutten, F. (1994) · Health Economics · doi:10.1002/hec.4730030606 · Cited by 90
Self-citation
Cyclical variation in vacancy durations and vacancy flows
OURS, J. C. V., & Ridder, G. (1991) · European Economic Review · doi:10.1016/0014-2921(91)90010-g · Cited by 41
Costs of illness in Sweden, 1964-1975
Lindgren, B. (1981) · Medical Entomology and Zoology · Cited by 27

Show all 9 references

Sorted by citations

Items 201–300 of 358

Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany
Gross, M., Beckenbauer, U. E., Burkowitz, J., Walther, H., & Brueggenjuergen, B. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-3-124 · Cited by 18
Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial
Marsden, J., Stillwell, G., Hellier, J. M., Brown, A. M., Byford, S., Kelleher, M., Kelly, J., Murphy, C., Shearer, J., & Mitcheson, L. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.003 · Cited by 16
The potential health and economic effects of plant-based food patterns in Belgium and the United Kingdom
Schepers, J., & Annemans, L. (2017) · Nutrition · doi:10.1016/j.nut.2017.11.028 · Cited by 17
Review of the costs of illness of ankylosing spondylitis and methodologic notes
Boonen, A. E. R. C. H., & van der Heijde, D. M. F. M. (2005) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.5.2.163 · Cited by 17
Economic Benefits of Achieving Realistic Smoking Cessation Targets in Australia
Magnus, A., Cadilhac, D. A.-M., Sheppard, L., Cumming, T. B., Pearce, D. C., & Carter, R. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.191056 · Cited by 17
Treatment of Migraine in Canada With Naratriptan: A Cost‐Effectiveness Analysis
Jaime, J., Getsios, D., Raggio, G., Caro, G., & Black, L. K. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.01083.x · Cited by 17
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
Shah, P. K., Glueck, C. J., Jetty, V., Goldenberg, N., Rothschild, M., Riaz, R., Duhon, G., & Wang, P. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0302-8 · Cited by 15
“In human health-economics there are two major approaches: the human capital approach, and the friction cost method [37–40].”
Method
The economic cost of epilepsy: a review
Brunetti, M., Pagano, E., & Garattini, L. (1998) · Neurological Sciences · doi:10.1007/bf02427569 · Cited by 16
Short Form- Health and Labour Questionnaire (SF-HLQ)
Roijen, L. H. (2010) · Cited by 15
A trial-based economic evaluation of the Restore4Stroke self-management intervention compared to an education-based intervention for stroke patients and their partners
van Mastrigt, G. A. P. G., van Eeden, M., Heugten, C. M. V., Tielemans, N. S., Schepers, V. P. M., & Evers, S. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05103-x · Cited by 15
Use of the Stanford Health Assessment Questionnaire in estimation of long‐term productivity costs in patients with recent‐onset rheumatoid arthritis
Puolakka, K., Kautiainen, H., Möttönen, T. T., Hannonen, P., Korpela, M. M., Hakala, M., Luukkainen, R., Vuori, K., Blåfield, H., Leirisalo‐Repo, M., et al. (2009) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740902756515 · Cited by 15
Mechanical neck pain
Dennison, B. S., & Leal, M. H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3528-9.00007-8 · Cited by 15
Productivity outcomes from chronic pain management interventions in the working age population; a systematic review
Chowdhury, A. R., Graham, P. L., Schofield, D., Costa, D. S. J., & Nicholas, M. (2024) · Pain · doi:10.1097/j.pain.0000000000003149 · Cited by 15
“23 The FCM restricts costs of productivity loss to the friction period—the period it takes to replace a worker because of illness, although internal resource reserves are taking up the work of a missing employee and the duration and the costs of hiring and training new workers taking into account…”
Background
Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data
Landstedt‐Hallin, L., Gundgaard, J., Ericsson, Å., & Ellfors-Zetterlund, S. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1277194 · Cited by 14
The Cost of Cochlear Implantation: A Review of Methodological Considerations
Costa, N., Garnault, V., Ferlicoq, L., Derumeaux-Burel, H., Bongard, V., Déguine, O., Fraysse, B., & Molinier, L. (2011) · International Journal of Otolaryngology · doi:10.1155/2011/210838 · Cited by 14
“When production losses because of mortality are not considered, future lost earnings are neglected [40, 41].”
BackgroundMethod
Assessing the economics of vaccination forNeisseria meningitidisin industrialized nations: A review and recommendations for further research
Getsios, D., Caro, I., El-Hadi, W., & Jaime, J. (2004) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462304001096 · Cited by 14
Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial
Blackwood, R., Wolstenholme, A., Kimergård, A., Fincham-Campbell, S., Khadjesari, Z., Coulton, S., Byford, S., Deluca, P., Jennings, S., Currell, E. A., et al. (2020) · BMC Public Health · doi:10.1186/s12889-020-8437-y · Cited by 13
The burden-of-illness study on osteoporosis in the Slovenian female population
Dzajkovska, B., Wertheimer, A. I., & Mrhar, A. (2007) · Pharmacy World & Science · doi:10.1007/s11096-007-9091-5 · Cited by 13
Disability and cost for diabetic patients at a public district hospital in Thailand
Riewpaiboon, A., Chatterjee, S., Riewpaiboon, W., & Piyauthakit, P. (2011) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2010.00078.x · Cited by 13
“Finally, it should be noted that the productivity costs may be overestimated if the human-capital approach is used to calculate such costs, which is why the frictional-cost approach is preferred.([18,28]) However, the information needed to apply the friction-cost approach was not available at the time of the study, he…”
Background
Obsessive Compulsive Treatment Efficacy Trial (OCTET) comparing the clinical and cost effectiveness of self-managed therapies: study protocol for a randomised controlled trial
Gellatly, J. L., Bower, P., McMillan, D., Roberts, C., Byford, S., Bee, P., Gilbody, S. M., Arundel, C., Hardy, G. E., Barkham, M., et al. (2014) · Trials · doi:10.1186/1745-6215-15-278 · Cited by 12
“Productivity losses will be calculated using the human capital approach, which involves multiplying days off work due to illness by the individual’s salary [44].”
Method
Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists
Ashford, P., Knight, C., Heslin, M., Clark, A., Kanaan, M. N., Patel, U. J., Stuart, F., Kabir, T., Grey, N., Murray, H., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056355 · Cited by 12
APPROACHES TO ESTIMATING INDIRECT COSTS IN HEALTHCARE: MOTIVATIONS FOR CHOICE
Mennini, F. S., & Gitto, L. (2022) · JOURNAL OF EUROPEAN ECONOMY · doi:10.35774/jee2022.01.017 · Cited by 12
“In the subsequent study by Koopmanschap and Rutten (1996), a practical guide is provided for the quantification and exploitation of indirect disease costs, both at the aggregate level of general cost of disease studies, and in an economic assessment of precise health programs4.”
BackgroundMethodInfluential
Cost of privatisation versus government alcohol retailing systems: Canadian example
Popova, S., Patra, J., Sarnocinska-Hart, A., Gnam, W., Giesbrecht, N., & Rehm, J. T. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00276.x · Cited by 12
“During the replacement period that lasts approximately 3 months [33], the value of goods and services that a prematurely deceased person would have produced is lost forever to the society—this value is called a friction cost.”
Background
Kosteneffizienzvergleich von Physiotherapie, manueller Therapie und hausärztlicher Therapie in der Behandlung von Nackenschmerzen
Bos, I. B. C. K., Hoving, J. L., van Tulder, M. W., Mölken, M. R., Adler, H., de Vet, H. C. W., Koes, B. W., Vondeling, H., & Bouter, L. M. (2005) · Manuelle Medizin · doi:10.1007/s00337-005-0383-3 · Cited by 12
Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial
Berenguera, A., Ribera, E. P., Rodríguez-Blanco, T., Violán, C., Casajuana‐Closas, M., de Kort, N., & Trapero‐Bertran, M. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-194 · Cited by 11
Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial
Pérez, J., Russo, D. A., Štochl, J., Byford, S., Zimbron, J., Graffy, J., Painter, M., Croudace, T. J., & Jones, P. B. (2013) · Trials · doi:10.1186/1745-6215-14-222 · Cited by 11
“Productivity losses, for young people who are working, will be calculated using the human capital approach, which involves multiplying time off work due to illness by the participant’s salary [20].”
Method
Economic evaluation of empirical antisecretory therapy versusHelicobacter pylorifor management of dyspepsia: A randomized trial in primary care
Jarbøl, D. E., Bech, M., Kragstrup, J., Havelund, T., & de Muckadell, O. B. S. (2006) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462306051269 · Cited by 11
The Pharmacoeconomics of the New Antiepileptic Drugs
Heaney, D. C. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00944.x · Cited by 11
Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia
Hafner, M., Yerushalmi, E., Andersson, F., & Burtea, T. (2022) · Health Economics · doi:10.1002/hec.4638 · Cited by 9
Effect of video-assisted patient education on compliance with therapy, quality of life, psychomorbidity, and cost of illness in irritable bowel syndrome
Kamat, N., Mallayasamy, S. R., Sharma, P., Kamath, A., & Pai, C. G. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2019.1549458 · Cited by 10
“Indirect costs included lost productivity and absenteeism [14].”
Background
Psychosomatic therapy for patients frequently attending primary care with medically unexplained symptoms, the CORPUS trial: study protocol for a randomised controlled trial
Wortman, M. S. H., van der Wouden, J. C., Grutters, J. P. C., Visser, B., Assendelft, W. J., van der Horst, H. E., & Hartman, T. O. (2019) · Trials · doi:10.1186/s13063-019-3913-3 · Cited by 10
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model
Kremer, I., Hiligsmann, M., Carlson, J. J., Zimmermann, M. R., Jongen, P. J., Evers, S., Petersohn, S., Pouwels, X., & Bansback, N. J. (2020) · Medical Decision Making · doi:10.1177/0272989x20961091 · Cited by 10
“A sensitivity analysis was conducted in which productivity losses also included the costs of long-term absence, disability, and early retirement, according to the human capital approach.(73) Relapse costs were also derived from Uitdehaag et al.”
Method
Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study)
Henrichs, J., de Jonge, A., Westerneng, M., Verfaille, V., Franx, A., van der Horst, H. E., Bosmans, J. E., & on behalf of the IRIS Study Group (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063312 · Cited by 11
“The friction cost approach (friction period 85 days) was used to estimate lost productivity costs using Dutch rates [18,29].”
BackgroundMethod
Cost of low back pain in Switzerland in 2005 Simon WieserBruno HorisbergerSara SchmidhauserClaudia Eisenring • Urs BruggerAndreas RuckstuhlJurg DietrichAnne F. Mannion •
Wieser, S., Horisberger, B., Schmidhauser, S., Ruckstuhl, A., Dietrich, J., Mannion, A. F., Klinik, S., & Elfering, A. (2011) · Cited by 10
Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial
Goranitis, I., Bellanca, L., Daley, A., Thomas, A., Stokes-Lampard, H. J., Roalfe, A. K., & Jowett, S. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184328 · Cited by 10
“Fourth, the human capital approach tends to overestimate productivity losses [75, 76].”
Background
Understanding the Non-medical Costs of Healthcare: Evidence from Inpatient Care for Older People in China
Yang, W. Y. L. (2019) · The China Quarterly · doi:10.1017/s0305741019001115 · Cited by 10
Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis
Tran-Duy, A., Boonen, A., Kievit, W., van Riel, P., van de Laar, M. A., & Severens, J. (2014) · PharmacoEconomics (Auckland) · doi:10.1007/s40273-014-0184-4 · Cited by 11
“The human capital approach was used for estimating sick leave cost [34].”
Ensuring Appropriate Care in Epilepsy
Heaney, D. C., & Sander, J. W. A. S. (1998) · Disease Management & Health Outcomes · doi:10.2165/00115677-199804060-00001 · Cited by 10
Feasibility of a theory-based intervention to reduce sedentary behaviour among contact centre staff: the SUH stepped-wedge cluster RCT
Jepson, R. G., Baker, G., Sivaramakrishnan, D., Manner, J., Parker, R. A., Lloyd, S., & Stoddart, A. (2022) · Public Health Research · doi:10.3310/iexp0277 · Cited by 10
Measurement strategies for indirect costs in economic evaluations
Evans, C., Mertzanis, P., & Abetz, L. N. (2003) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.3.6.703 · Cited by 9
Health economy of the metabolic syndrome pandemic
Hedner, T., Kjeldsen, S. E., & Narkiewicz, K. (2005) · Blood Pressure · doi:10.1080/08037051510034310 · Cited by 9
Cost Estimates for Chronic Diseases
Woo, J., & Cockram, C. S. (2000) · Disease Management & Health Outcomes · doi:10.2165/00115677-200008010-00004 · Cited by 9
Productivity cost model of the treatment of rheumatoid arthritis with abatacept
Burton, W. N., Morrison, A., Yuan, Y., Li, T. M. W. Y., Marioni, R. E., & Maclean, R. (2008) · Journal of Medical Economics · doi:10.3111/13696990701748837 · Cited by 8
Economic burden to primary informal caregivers of hospitalized older adults in Mexico: a cohort study
Ortega, M. L., García‐Peña, C., Granados-García, V., González, J. J. G., & Pérez‐Zepeda, M. U. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-51 · Cited by 8
Lohnt sich Rehabilitation?
Krauth, C., & Bartling, T. (2017) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-017-2514-0 · Cited by 8
Direct and indirect costs of paediatric asthma in the UK: a cost analysis
Kennedy, C., Scotland, G., Cotton, S. C., & Turner, S. (2024) · Archives of Disease in Childhood · doi:10.1136/archdischild-2023-326306 · Cited by 7
Study protocol of an economic evaluation of an extended implementation strategy for the treatment of low back pain in general practice: a cluster randomised controlled trial
Jensen, C. E., Riis, A., Pedersen, K. M., Jensen, M. B., & Petersen, K. D. (2014) · Implementation Science · doi:10.1186/s13012-014-0140-x · Cited by 7
Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT
Seppen, B. F., Greuter, M. J. E., Wiegel, J., ter Wee, M. M., Boers, M., Nurmohamed, M. T., & Bos, W. H. (2023) · Lara D. Veeken · doi:10.1093/rheumatology/kead084 · Cited by 7
“The IPCQ was used to calculate the total productivity loss due to both absenteeism (days on sick leave) and presenteeism (days with productivity loss while at work) based on the friction cost approach [17].”
Method
Economic analysis model for inpatient parenteral nutrition: A pilot study
Poole, R., Gillanders, L. K., Plank, L. D., McIlroy, K., DAVOREN, H., & Parry, B. R. (2009) · Nutrition & Dietetics · doi:10.1111/j.1747-0080.2009.01374.x · Cited by 7
Inclusión de análisis farmacoeconómicos en ensayos clínicos: principios y prácticas
Álvarez, J. S. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73658-6 · Cited by 7
The Cost of Lung Cancer Management in France from the Payor???s Perspective
gre, A. V., Molinier, L., Combescure, C., s, J.-P. D., HOUSSET, B., & CHOUAID, C. (2006) · Disease Management & Health Outcomes · doi:10.2165/00115677-200614010-00007 · Cited by 7
Cost of schizophrenia studies: a methodological review
Tediosi, F., Parazzini, F., & Garattini, L. (2000) · The European Journal of Health Economics · doi:10.1007/s101980050004 · Cited by 7
The Burden of Gastrointestinal and Liver Diseases
Shaheen, N. J. (2007) · doi:10.1002/9780470692189.ch2 · Cited by 7
The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study
Bouleau, A., Dulong, C., Schwerer, C., Delgrange, R., Bouaou, K., Brochu, T., Zinaï, S., Švecová, K., Sá, M. J., Petropoulos, A., et al. (2022) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173221093219 · Cited by 6
The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE Trial
Cox, E., Walker, S., Blower, S. L., Sampaio, F., Bywater, T. J., & Richardson, G. A. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08220-x · Cited by 6
“Intervention-related unit costs were based on recorded trial costs; childcare costs were informed by relevant surveys [20, 21]; health care, social care and community service costs were sourced from published UK sources [22, 23]; and absent workday productivity losses were estimated using the human capital approach [2…”
Method
Economic burden of chronic obstructive pulmonary disease in Morocco: a cost of illness study
Benmaamar, S., Es-Sabbahi, B., Haiba, M. T., Omari, M., Harch, I. E., Youbi, M., Belakhel, L., Abousselham, L., Hachri, H., Menchawy, I. E., et al. (2024) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2024.2745 · Cited by 6
“Indirect cost represented by labor productivity lost by the patient was measured using the human capital method [23,24].”
Method
Health Economics of Infectious Diseases
Welte, R., Leidl, R., Greiner, W., & Postma, M. J. (2009) · Statistics in the health sciences · doi:10.1007/978-0-387-93835-6_15 · Cited by 6
Carga de la enfermedad atribuible al hipotiroidismo subclínico en la población española
Donnay, S., Balsa, J. A., Álvarez, J., Crespo, C., Pérez-Alcántara, F., & Polanco, C. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.04.009 · Cited by 6
Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial
ter Wee, M. M., Coupé, V. M. H., den Uyl, D., Blomjous, B. S., Kooijmans, E. C. M., Kerstens, P. J. S. M., Nurmohamed, M. T., van Schaardenburg, D., Voskuyl, A. E., Boers, M., et al. (2017) · RMD Open · doi:10.1136/rmdopen-2017-000502 · Cited by 6
“ACR/Boolean remission 14 (17) 12 (15) 0.”
Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease
Burgers, L., Redekop, W., & Severens, J. (2014) · PharmacoEconomics (Auckland) · doi:10.1007/s40273-014-0155-9 · Cited by 5
EL COSTE DE OPORTUNIDAD DEL TIEMPO REMUNERADO EN LA PRODUCCIÓN DE SALUD
Prades, J. L. P., & Puig‐Junoy, J. (2001) · Cited by 6
El coste social de la depresión en la ciudad de Sabadell (2007-2008)
Pàmias, M., Crespo, C., Gelonch, R. G., & Palao, D. J. (2011) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2011.07.019 · Cited by 5
Service and Wider Societal Costs of Very Young Children with Autism in the UK
Barrett, B. M., Byford, S., Sharac, J., Hudry, K., Leadbitter, K., Temple, K., Aldred, C. R., Slonims, V., & Green, J. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1393-8 · Cited by 8
Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study
Tran‐Duy, A., Boonen, A. E. R. C. H., van de Laar, M. A. F. J., & Severens, J. L. (2015) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-015-0044-x · Cited by 5
“Productivity costs were computed using the human capital approach [31].”
Method
Do costs of varicella justify routine infant vaccination?
Postma, M. J., Bos, J. M., Welte, R., de Groot, R., Luytjes, W., R�mke, H. C., & Beutels, P. (2004) · The European Journal of Health Economics · doi:10.1007/s10198-003-0201-6 · Cited by 5
Economic Value of Thrombolysis with Adjunctive Abciximab in Patients with Subacute Peripheral Arterial Occlusion
Duda, S. H., Tepe, G., BALA, M. M., Luz, O., Ziemer, G., Ouriel, K. M., Pusich, B., Wiskirchen, J., Claussen, C. D., & Banz, K. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220030-00006 · Cited by 5
“Indirect costs in terms of work loss were estimated by adopting the human capital approach, which is a common method for the valuation of productivity losses.[14,15] This method assesses the value of lost production based on the lost average income of a gainfully employed person.”
Method
Neglected equity issues in cost effectiveness analysis – part 2: direct and indirect costs, the preservation of hope, the rule of rescue, patient adaptation, and the ex ante/ex post distinctio
Mckie, J. R., & Richardson, J. R. J. (2017) · Figshare · doi:10.26180/5073856 · Cited by 5
Cost-effectiveness of a nurse-led intervention to optimise implementation of guideline-concordant continence care: Study protocol of the COCON study
Jansen, A. P. D., Muntinga, M. E., Bosmans, J. E., Berghmans, B. C. M., Dekker, J. H., Hugtenburgh, J., Nijpels, G., van Houten, P., Laurant, M. G. H., & van der Vaart, C. H. (2017) · BMC Nursing · doi:10.1186/s12912-017-0204-8 · Cited by 5
“The friction cost approach will be used to estimate lost productivity costs [47].”
Method
Health economic studies on advanced home care
Andersson, A. (2002) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 5
Aan roken toe te schrijven productiviteitskosten voor Nederlandse werkgevers in 1999
Mam, J.-V. D. B., Ra, W., Koopmanschap, M., & Jager, J. C. (2002) · Rivm (National Institute for Public Health and the Environment) · Cited by 5
Self-citation
Assessment of hospitalization costs and its determinants in infants with clinical severe infection at a public tertiary hospital in Nepal
Shrestha, S., Chapagain, R. H., Purakayastha, D. R., Basnet, S., Wadhwa, N., Strand, T. A., & Basnet, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260127 · Cited by 4
“Indirect cost, defined as work time loss of parents [27], was computed based on several assumptions.”
Method
Cost-effectiveness of psychotropic polypharmacy in routine schizophrenia care. Results of the ELAN prospective observational trial
Kilian, R., Frasch, K., Steinert, T., Schepp, W., Weiser, P., Jaeger, S., Pfiffner, C., Eschweiler, G. W., Messer, T., Croissant, D., et al. (2018) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2018.05.004 · Cited by 4
Cost analysis of procedures related to the management of renal artery stenosis from various perspectives
van Helvoort-Postulart, D., Dirksen, C. D., Kroon, A. A., Nelemans, P. J., de Leeuw, P. W., Kessels, A. G. H., van Engelshoven, J. M. A., & Hunink, M. G. M. (2005) · European Radiology · doi:10.1007/s00330-005-2821-y · Cited by 4
Methoden zur vergleichenden Bewertung pharmazeutischer Produkte
Zentner, A., Velasco-Garrido, M., & Busse, R. (2005) · German Medical Science (German Research Foundation) · Cited by 4
How Chiropractors began working in a Community Health Centre in Ottawa.
Baskerville, N. B., & Keenan, D. (2005) · PubMed Central · Cited by 4
Burden of illness attributable to subclinical hypothyroidism in the Spanish population
Donnay, S., Balsa, J. A., Álvarez, J., Crespo, C., Pérez-Alcántara, F., & Polanco, C. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2013.07.002 · Cited by 3
Alcohol-Related Laws and Avoidable Burden and its Costs Due to Motor Vehicle Collisions in Canada
Popova, S., Patra, J., Sarnocinska-Hart, A., Gnam, W., Mann, R. E., & Rehm, J. T. (2011) · Contemporary Drug Problems · doi:10.1177/009145091103800307 · Cited by 3
“For practical calculations, Koopmanschap and Rutten (1996) suggested that the replacement period for a worker had a mean of 3 months.”
BackgroundMethod
Economic analyses and lung cancer.
Vergnenégre, A., Molinier, L., & CHOUAID, C. (2001) · PubMed · Cited by 3
A proportionate, universal parenting programme to enhance social-emotional well-being in infants and toddlers in England: the E-SEE Steps RCT
Bywater, T. J., Berry, V., Blower, S. L., Bursnall, M., Cox, E., Mason‐Jones, A. J., McGilloway, S., McKendrick, K., Mitchell, S. B., Pickett, K. E., et al. (2022) · Public Health Research · doi:10.3310/bcfv2964 · Cited by 3
Allocating resources in health care
Gandjour, A., & Lauterbach, K. W. (2000) · The European Journal of Health Economics · doi:10.1007/s101980070005 · Cited by 3
Methoden zur Kostenerfassungim Rahmen der ökonomischen Evaluation einer Rehabilitations-maßnahme bei chronischen Atemwegserkrankungen
Hessel, F. P., Wittmann, M., Petro, W., & Wasem, J. (2000) · Pneumologie · doi:10.1055/s-2000-4455 · Cited by 3
Employer survey to estimate the productivity friction period
Manipis, K., Goodall, S., Hanly, P. A., Viney, R. C., & Pearce, A. M. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-020-01250-4 · Cited by 2
“Aside from the productivity that is lost during a friction period, there are additional costs that may be incurred in replacing a sick worker [2].”
Background
Potential health and economic impact of achieving Kenya’s overweight and obesity reduction target: a modelling study
Wanjau, M. N., Aminde, L. N., & Veerman, L. J. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000566 · Cited by 2
“38 39 Studies that estimated both direct and indirect costs of obesity found productivity-related costs higher than the direct healthcare costs.”
Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study
Manipis, K., Cronin, P., Street, D. J., Church, J., Viney, R. C., & Goodall, S. (2025) · PharmacoEconomics · doi:10.1007/s40273-024-01458-9 · Cited by 3
“The firm also bears additional costs associated with replacing a worker, which include recruitment decisions and training costs [16, 61].”
Influential
BENEFITS OF PHARMACEUTICAL INNOVATION: THE CASE OF SIMVASTATIN IN CANADA
Thành, N. X., Chuck, A. W., Ohinmaa, A. E., & Jacobs, P. (2012) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462312000499 · Cited by 2
“We estimated the costs of lost productivity using a human capital approach (17).”
BackgroundMethod
[Economic aspects of ambulatory and inpatient treatment of HIV positive patients].
Stoll, M., & Schmidt, R. E. (2003) · PubMed · Cited by 2
How Health Affects Productivity
Bevan, S., & Cooper, C. L. (2021) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-83867-499-120211002 · Cited by 2
Análisis de minimización de costes del tratamiento del dolor neuropático periférico en España con parches cutáneos 179 mg de capsaicina (8%) frente a gabapentinoides
Bernal, D. S., Vergara, I. P., Torres, N. V., & Pérez-Mitru, A. (2019) · Economía de la Salud · doi:10.61679/140510121025 · Cited by 2
Ökonomische Aspekte der ambulanten und stationären Behandlung HIV-Infizierter
Stoll, M., & Schmidt, R. E. (2003) · Der Internist · doi:10.1007/s00108-003-0922-8 · Cited by 2
Estimating the Indirect Costs of Smoking Using the Friction Cost Method
Koopmanschap, M. A. (1999) · Studies in risk and uncertainty · doi:10.1007/978-94-011-4415-5_4 · Cited by 2
Self-citation
Custos hospitalares da meningite causada por Streptococcus pneumoniae na cidade de São José dos Campos, SP
Lucarevschi, B. R. (2010) · doi:10.11606/t.5.2010.tde-03112010-163716 · Cited by 2
Uso de modelos de análise de decisão nos programas de vacinação contra a varicela
de Soárez, P. C. (2009) · doi:10.11606/t.5.2009.tde-09122009-162209 · Cited by 2
The Economics of Presenteeism: A discrete choice & count model frameworkPreprint
Pedersen, K. M., & Skagen, K. (2014) · RePEc: Research Papers in Economics · Cited by 2
Indirekte Kosten bei HIV-Positiven
Claes, C., Schulte, E., Körner, T., Kuhlmann, B., von der Schulenburg, G. J. M., Schmidt, R. E., & Stoll, M. (2000) · Springer eBooks · doi:10.1007/978-3-642-59683-4_31 · Cited by 2
Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia − 2020–2021
Gobin, S., Sahakyan, G., Appiah, M. K., Manukyan, A., Palayan, K., Ebama, M., Vanyan, A. V., McCarron, M., & Bresee, J. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.05.055 · Cited by 1
Economic Burden of Ischemic Heart Disease in Morocco: Evidence From a Teaching Hospital, a Cost-of-Illness Study
Maiouak, M., Cherti, M., Youbi, M., Belakhel, L., Abousselham, L., Fakir, S. E., Berraho, M., Menchawy, I. E., Benmessaoud, F., & Tachfouti, N. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101504 · Cited by 1
Clinical, humanistic, and economic burden of haemophilia A in China: findings from a real-world survey
Feng, J., Dou, L., Chen, J., Fang, Y., Cheng, Y., & Li, S. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-04051-1 · Cited by 1
“Indirect costs were defined as those related to absenteeism, presenteeism, early retirement, or forced unemployment due to the disease burden, valued using the human capital approach [29, 30].”
Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease: a cost–utility analysis
Kalverda, K., van Barreveld, M., Bonta, P., Daniels, J. M. A., Dickhoff, C., Korevaar, D. A., Annema, J., & Dijkgraaf, M. (2025) · ERJ Open Research · doi:10.1183/23120541.00629-2025 · Cited by 1
Clinical Effectiveness and Cost‐Effectiveness of Misoprostol in Comparison to Dilatation and Curettage for Treatment of First‐Trimester Missed Abortion (Gestational Age ≤ 14 Weeks) in Iran
Barghazan, S. H., Hadian, M., Rezapour, A., Nassiri, S., Meshkani, Z. S., & Norouzi, S. (2025) · Health Science Reports · doi:10.1002/hsr2.71662 · Cited by 2
“• Transportation costs were estimated using average round‐ trip fares reported by patients for hospital visits [24, 25].”
Using a return on investment analysis to estimate the economic impact of potential changes to alcohol control policies in Estonia
Rovira, P., Lai, T., Reile, R., Hassan, A. S., & Rehm, J. T. (2026) · European Journal of Public Health · doi:10.1093/eurpub/ckaf265 · Cited by 1
“For productivity losses due to premature mortality, we followed a human capital approach [29].”

Authors: Koopmanschap, M. A., & Rutten, F. F. H.
Affiliations: Erasmus University Rotterdam (NL)
Corresponding author: Koopmanschap, Marc A.
Venue: PharmacoEconomics
Publisher: Springer Science and Business Media LLC
Published: 1996-11
Volume: 10
Issue: 5
Pages: 460-466
ISSN: 1170-7690 (ISSN-L)
DOI: 10.2165/00019053-199610050-00003
OpenAlex: W1980604588
Cited by: 358
References: 9
Citations by year: 2026: 7 · 2025: 5 · 2024: 8 · 2023: 2 · 2022: 17 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 10 · 2017: 19 · 2016: 11 · 2015: 11 · 2014: 14 · 2013: 12 · 2012: 8
FWCI: 22.73
Type: journal article
Language: en
Open access: closed
Locations: PharmacoEconomics (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
Keywords: economic burden, human capital approach, friction cost method, productivity loss, economic evaluation, labor shortage, cost estimation
MeSH terms: Cost-Benefit Analysis, Delivery of Health Care, Humans, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Practical Guide for Calculating Indirect Costs of Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks